ID   GLMU_HAEIN              Reviewed;         456 AA.
AC   P43889;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1995, sequence version 1.
DT   29-APR-2015, entry version 114.
DE   RecName: Full=Bifunctional protein GlmU;
DE   Includes:
DE     RecName: Full=UDP-N-acetylglucosamine pyrophosphorylase;
DE              EC=2.7.7.23;
DE     AltName: Full=N-acetylglucosamine-1-phosphate uridyltransferase;
DE   Includes:
DE     RecName: Full=Glucosamine-1-phosphate N-acetyltransferase;
DE              EC=2.3.1.157;
GN   Name=glmU; OrderedLocusNames=HI_0642;
OS   Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Pasteurellales;
OC   Pasteurellaceae; Haemophilus.
OX   NCBI_TaxID=71421;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=ATCC 51907 / DSM 11121 / KW20 / Rd;
RX   PubMed=7542800; DOI=10.1126/science.7542800;
RA   Fleischmann R.D., Adams M.D., White O., Clayton R.A., Kirkness E.F.,
RA   Kerlavage A.R., Bult C.J., Tomb J.-F., Dougherty B.A., Merrick J.M.,
RA   McKenney K., Sutton G.G., FitzHugh W., Fields C.A., Gocayne J.D.,
RA   Scott J.D., Shirley R., Liu L.-I., Glodek A., Kelley J.M.,
RA   Weidman J.F., Phillips C.A., Spriggs T., Hedblom E., Cotton M.D.,
RA   Utterback T.R., Hanna M.C., Nguyen D.T., Saudek D.M., Brandon R.C.,
RA   Fine L.D., Fritchman J.L., Fuhrmann J.L., Geoghagen N.S.M.,
RA   Gnehm C.L., McDonald L.A., Small K.V., Fraser C.M., Smith H.O.,
RA   Venter J.C.;
RT   "Whole-genome random sequencing and assembly of Haemophilus influenzae
RT   Rd.";
RL   Science 269:496-512(1995).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.79 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS, FUNCTION, MUTAGENESIS OF LYS-25; GLN-76; TYR-103; ASP-105;
RP   VAL-223 AND GLU-224, REACTION MECHANISM, AND SUBUNIT.
RX   PubMed=18029420; DOI=10.1110/ps.073135107;
RA   Mochalkin I., Lightle S., Zhu Y., Ohren J.F., Spessard C.,
RA   Chirgadze N.Y., Banotai C., Melnick M., McDowell L.;
RT   "Characterization of substrate binding and catalysis in the potential
RT   antibacterial target N-acetylglucosamine-1-phosphate uridyltransferase
RT   (GlmU).";
RL   Protein Sci. 16:2657-2666(2007).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS, AND SUBUNIT.
RX   PubMed=18218712; DOI=10.1110/ps.073271408;
RA   Mochalkin I., Lightle S., Narasimhan L., Bornemeier D., Melnick M.,
RA   Vanderroest S., McDowell L.;
RT   "Structure of a small-molecule inhibitor complexed with GlmU from
RT   Haemophilus influenzae reveals an allosteric binding site.";
RL   Protein Sci. 17:577-582(2008).
RN   [4]
RP   X-RAY CRYSTALLOGRAPHY (1.99 ANGSTROMS) IN COMPLEX WITH SUBSTRATE
RP   ANALOGS.
RA   Melnick M., Mochalkin I., Lightle S., Narasimhan L., Mcdowell L.,
RA   Sarver R.;
RT   "Discovery and initial sar of quinazoline inhibitors of GlmU from
RT   Haemophilus influenzae.";
RL   Submitted (OCT-2008) to the PDB data bank.
CC   -!- FUNCTION: Catalyzes the last two sequential reactions in the de
CC       novo biosynthetic pathway for UDP-N-acetylglucosamine (UDP-
CC       GlcNAc). The C-terminal domain catalyzes the transfer of acetyl
CC       group from acetyl coenzyme A to glucosamine-1-phosphate (GlcN-1-P)
CC       to produce N-acetylglucosamine-1-phosphate (GlcNAc-1-P), which is
CC       converted into UDP-GlcNAc by the transfer of uridine 5-
CC       monophosphate (from uridine 5-triphosphate), a reaction catalyzed
CC       by the N-terminal domain. {ECO:0000269|PubMed:18029420}.
CC   -!- CATALYTIC ACTIVITY: Acetyl-CoA + alpha-D-glucosamine 1-phosphate =
CC       CoA + N-acetyl-alpha-D-glucosamine 1-phosphate.
CC   -!- CATALYTIC ACTIVITY: UTP + N-acetyl-alpha-D-glucosamine 1-phosphate
CC       = diphosphate + UDP-N-acetyl-alpha-D-glucosamine.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420; Evidence={ECO:0000250};
CC       Note=Binds 1 Mg(2+) ion per subunit. {ECO:0000250};
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; UDP-N-acetyl-alpha-D-
CC       glucosamine biosynthesis; N-acetyl-alpha-D-glucosamine 1-phosphate
CC       from alpha-D-glucosamine 6-phosphate (route II): step 2/2.
CC   -!- PATHWAY: Nucleotide-sugar biosynthesis; UDP-N-acetyl-alpha-D-
CC       glucosamine biosynthesis; UDP-N-acetyl-alpha-D-glucosamine from N-
CC       acetyl-alpha-D-glucosamine 1-phosphate: step 1/1.
CC   -!- PATHWAY: Bacterial outer membrane biogenesis; LPS lipid A
CC       biosynthesis.
CC   -!- SUBUNIT: Homotrimer. {ECO:0000269|PubMed:18029420,
CC       ECO:0000269|PubMed:18218712, ECO:0000269|Ref.4}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the N-
CC       acetylglucosamine-1-phosphate uridyltransferase family.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the transferase
CC       hexapeptide repeat family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L42023; AAC22302.1; -; Genomic_DNA.
DR   PIR; G64083; G64083.
DR   RefSeq; NP_438802.1; NC_000907.1.
DR   RefSeq; WP_005694502.1; NC_000907.1.
DR   PDB; 2V0H; X-ray; 1.79 A; A=1-456.
DR   PDB; 2V0I; X-ray; 1.89 A; A=1-456.
DR   PDB; 2V0J; X-ray; 2.00 A; A=1-456.
DR   PDB; 2V0K; X-ray; 2.30 A; A=1-456.
DR   PDB; 2V0L; X-ray; 2.20 A; A=1-456.
DR   PDB; 2VD4; X-ray; 1.90 A; A=1-456.
DR   PDB; 2W0V; X-ray; 1.99 A; A=1-456.
DR   PDB; 2W0W; X-ray; 2.59 A; A=1-456.
DR   PDB; 4E1K; X-ray; 2.00 A; A=1-456.
DR   PDB; 4KNR; X-ray; 2.10 A; A=1-456.
DR   PDB; 4KNX; X-ray; 1.90 A; A=1-456.
DR   PDB; 4KPX; X-ray; 2.21 A; A=1-456.
DR   PDB; 4KPZ; X-ray; 2.09 A; A=1-456.
DR   PDB; 4KQL; X-ray; 2.31 A; A=1-456.
DR   PDBsum; 2V0H; -.
DR   PDBsum; 2V0I; -.
DR   PDBsum; 2V0J; -.
DR   PDBsum; 2V0K; -.
DR   PDBsum; 2V0L; -.
DR   PDBsum; 2VD4; -.
DR   PDBsum; 2W0V; -.
DR   PDBsum; 2W0W; -.
DR   PDBsum; 4E1K; -.
DR   PDBsum; 4KNR; -.
DR   PDBsum; 4KNX; -.
DR   PDBsum; 4KPX; -.
DR   PDBsum; 4KPZ; -.
DR   PDBsum; 4KQL; -.
DR   ProteinModelPortal; P43889; -.
DR   SMR; P43889; 4-453.
DR   STRING; 71421.HI0642; -.
DR   BindingDB; P43889; -.
DR   EnsemblBacteria; AAC22302; AAC22302; HI_0642.
DR   GeneID; 949691; -.
DR   KEGG; hin:HI0642; -.
DR   PATRIC; 20189891; VBIHaeInf48452_0670.
DR   eggNOG; COG1207; -.
DR   KO; K04042; -.
DR   OMA; FAHARPK; -.
DR   OrthoDB; EOG6Z6FQZ; -.
DR   PhylomeDB; P43889; -.
DR   BRENDA; 2.7.7.23; 2529.
DR   UniPathway; UPA00113; UER00532.
DR   UniPathway; UPA00113; UER00533.
DR   UniPathway; UPA00973; -.
DR   EvolutionaryTrace; P43889; -.
DR   PRO; PR:P43889; -.
DR   Proteomes; UP000000579; Chromosome.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0019134; F:glucosamine-1-phosphate N-acetyltransferase activity; IEA:UniProtKB-HAMAP.
DR   GO; GO:0000287; F:magnesium ion binding; IEA:UniProtKB-HAMAP.
DR   GO; GO:0003977; F:UDP-N-acetylglucosamine diphosphorylase activity; IEA:UniProtKB-HAMAP.
DR   GO; GO:0000902; P:cell morphogenesis; IEA:UniProtKB-HAMAP.
DR   GO; GO:0071555; P:cell wall organization; IEA:UniProtKB-KW.
DR   GO; GO:0009245; P:lipid A biosynthetic process; IEA:UniProtKB-UniPathway.
DR   GO; GO:0009103; P:lipopolysaccharide biosynthetic process; IEA:InterPro.
DR   GO; GO:0009252; P:peptidoglycan biosynthetic process; IEA:UniProtKB-HAMAP.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:UniProtKB-KW.
DR   GO; GO:0006048; P:UDP-N-acetylglucosamine biosynthetic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.90.550.10; -; 1.
DR   HAMAP; MF_01631; GlmU; 1.
DR   InterPro; IPR005882; Bifunctional_GlmU.
DR   InterPro; IPR001451; Hexapep_transf.
DR   InterPro; IPR018357; Hexapep_transf_CS.
DR   InterPro; IPR025877; MobA-like_NTP_Trfase_dom.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   InterPro; IPR011004; Trimer_LpxA-like.
DR   Pfam; PF00132; Hexapep; 4.
DR   Pfam; PF12804; NTP_transf_3; 1.
DR   SUPFAM; SSF51161; SSF51161; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
DR   TIGRFAMs; TIGR01173; glmU; 1.
DR   PROSITE; PS00101; HEXAPEP_TRANSFERASES; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acyltransferase; Cell shape;
KW   Cell wall biogenesis/degradation; Complete proteome; Cytoplasm;
KW   Magnesium; Metal-binding; Multifunctional enzyme;
KW   Nucleotidyltransferase; Peptidoglycan synthesis; Reference proteome;
KW   Repeat; Transferase.
FT   CHAIN         1    456       Bifunctional protein GlmU.
FT                                /FTId=PRO_0000068703.
FT   REGION        1    229       Pyrophosphorylase. {ECO:0000250}.
FT   REGION       11     14       UDP-GlcNAc binding.
FT   REGION       81     82       UDP-GlcNAc binding.
FT   REGION      103    105       UDP-GlcNAc binding.
FT   REGION      139    140       UDP-GlcNAc binding.
FT   REGION      224    227       UDP-GlcNAc binding.
FT   REGION      230    250       Linker. {ECO:0000250}.
FT   REGION      251    456       N-acetyltransferase. {ECO:0000250}.
FT   REGION      386    387       Acetyl-CoA binding. {ECO:0000250}.
FT   ACT_SITE    363    363       Proton acceptor. {ECO:0000250}.
FT   METAL       105    105       Magnesium. {ECO:0000250}.
FT   METAL       227    227       Magnesium. {ECO:0000250}.
FT   BINDING      25     25       UDP-GlcNAc. {ECO:0000250}.
FT   BINDING      76     76       UDP-GlcNAc.
FT   BINDING     140    140       UDP-GlcNAc; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING     154    154       UDP-GlcNAc.
FT   BINDING     169    169       UDP-GlcNAc.
FT   BINDING     227    227       UDP-GlcNAc. {ECO:0000250}.
FT   BINDING     333    333       Acetyl-CoA; amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING     351    351       Acetyl-CoA. {ECO:0000250}.
FT   BINDING     366    366       Acetyl-CoA. {ECO:0000250}.
FT   BINDING     377    377       Acetyl-CoA. {ECO:0000250}.
FT   BINDING     405    405       Acetyl-CoA. {ECO:0000250}.
FT   BINDING     423    423       Acetyl-CoA; via amide nitrogen.
FT                                {ECO:0000250}.
FT   BINDING     440    440       Acetyl-CoA. {ECO:0000250}.
FT   MUTAGEN      25     25       K->A: No pyrophosphorylase activity.
FT                                {ECO:0000269|PubMed:18029420}.
FT   MUTAGEN      76     76       Q->A: No pyrophosphorylase activity.
FT                                {ECO:0000269|PubMed:18029420}.
FT   MUTAGEN     103    103       Y->A: Reduces the pyrophosphorylase
FT                                activity. {ECO:0000269|PubMed:18029420}.
FT   MUTAGEN     105    105       D->A: No pyrophosphorylase activity.
FT                                {ECO:0000269|PubMed:18029420}.
FT   MUTAGEN     223    223       V->A: Reduces slightly the
FT                                pyrophosphorylase activity.
FT                                {ECO:0000269|PubMed:18029420}.
FT   MUTAGEN     224    224       E->A: Reduces the pyrophosphorylase
FT                                activity. {ECO:0000269|PubMed:18029420}.
FT   STRAND        6     11       {ECO:0000244|PDB:2V0H}.
FT   HELIX        17     19       {ECO:0000244|PDB:2V0H}.
FT   STRAND       21     23       {ECO:0000244|PDB:2V0H}.
FT   HELIX        25     27       {ECO:0000244|PDB:2V0H}.
FT   STRAND       28     30       {ECO:0000244|PDB:2V0H}.
FT   HELIX        35     45       {ECO:0000244|PDB:2V0H}.
FT   STRAND       51     55       {ECO:0000244|PDB:2V0H}.
FT   HELIX        59     65       {ECO:0000244|PDB:2V0H}.
FT   TURN         66     68       {ECO:0000244|PDB:2V0H}.
FT   STRAND       72     75       {ECO:0000244|PDB:2V0H}.
FT   HELIX        82     89       {ECO:0000244|PDB:2V0H}.
FT   HELIX        90     92       {ECO:0000244|PDB:2V0H}.
FT   STRAND       97    103       {ECO:0000244|PDB:2V0H}.
FT   HELIX       111    120       {ECO:0000244|PDB:2V0H}.
FT   STRAND      125    132       {ECO:0000244|PDB:2V0H}.
FT   STRAND      141    145       {ECO:0000244|PDB:2V0H}.
FT   STRAND      148    153       {ECO:0000244|PDB:2V0H}.
FT   TURN        155    157       {ECO:0000244|PDB:2V0H}.
FT   HELIX       160    163       {ECO:0000244|PDB:2V0H}.
FT   STRAND      167    176       {ECO:0000244|PDB:2V0H}.
FT   HELIX       177    184       {ECO:0000244|PDB:2V0H}.
FT   HELIX       198    200       {ECO:0000244|PDB:2V0H}.
FT   HELIX       201    207       {ECO:0000244|PDB:2V0H}.
FT   STRAND      212    216       {ECO:0000244|PDB:2V0H}.
FT   HELIX       221    223       {ECO:0000244|PDB:2V0H}.
FT   HELIX       229    249       {ECO:0000244|PDB:2V0H}.
FT   STRAND      253    255       {ECO:0000244|PDB:2V0H}.
FT   HELIX       257    259       {ECO:0000244|PDB:2V0H}.
FT   STRAND      260    268       {ECO:0000244|PDB:2V0H}.
FT   STRAND      276    286       {ECO:0000244|PDB:2V0H}.
FT   STRAND      297    303       {ECO:0000244|PDB:2V0H}.
FT   STRAND      314    320       {ECO:0000244|PDB:2V0H}.
FT   STRAND      328    332       {ECO:0000244|PDB:2V0H}.
FT   STRAND      336    338       {ECO:0000244|PDB:2W0W}.
FT   STRAND      343    352       {ECO:0000244|PDB:2V0H}.
FT   STRAND      360    372       {ECO:0000244|PDB:2V0H}.
FT   STRAND      383    386       {ECO:0000244|PDB:2V0H}.
FT   STRAND      388    391       {ECO:0000244|PDB:2V0H}.
FT   STRAND      395    397       {ECO:0000244|PDB:2V0H}.
FT   STRAND      408    415       {ECO:0000244|PDB:2V0H}.
SQ   SEQUENCE   456 AA;  49287 MW;  93B76552A8F9BD36 CRC64;
     MTKKALSAVI LAAGKGTRMY SDLPKVLHTI AGKPMVKHVI DTAHQLGSEN IHLIYGHGGD
     LMRTHLANEQ VNWVLQTEQL GTAHAVQQAA PFFKDNENIV VLYGDAPLIT KETLEKLIEA
     KPENGIALLT VNLDNPTGYG RIIRENGNVV AIVEQKDANA EQLNIKEVNT GVMVSDGASF
     KKWLARVGNN NAQGEYYLTD LIALANQDNC QVVAVQATDV MEVEGANNRL QLAALERYFQ
     NKQASKLLLE GVMIYDPARF DLRGTLEHGK DVEIDVNVII EGNVKLGDRV KIGTGCVLKN
     VVIGNDVEIK PYSVLEDSIV GEKAAIGPFS RLRPGAELAA ETHVGNFVEI KKSTVGKGSK
     VNHLTYVGDS EIGSNCNIGA GVITCNYDGA NKFKTIIGDD VFVGSDTQLV APVKVANGAT
     IGAGTTITRD VGENELVITR VAQRHIQGWQ RPIKKK
//
